A Long-term Follow-up Study for Cardiac Safety in the Patients with HER2 Positive Early or Locally Advanced Breast Cancer Who Have Completed the SB3-G31-BC
Study Type
OBSERVATIONAL
Enrollment
538
Intravenous administration
Intravenous administration
Number of Subjects With Asymptomatic Significant LVEF Decrease
Asymptomatic significant LVEF decrease is defined as LVEF decline ≥ 10% points from baseline and resulting LVEF \< 50%
Time frame: approximately 56 months (median follow-up duration)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Complex Oncological Center - Vratsa, EOOD
Vratsa, Bulgaria
ONKOCENTRUM Medicon Services s.r.o.
Prague, Czechia
CHU Besançon - Hôpital Jean Minjoz
Besançon, France
Centre Hospitalier de Belfort-Montbeliard
Montbéliard, France
Bialostockie Centrum Onkologii im.M.Sklodowskiej-Curie w Bialymstoku
Bialystok, Poland
Centrum Onkologii im. Prof. Franciszka Lukaszczyka w Bydgoszczy
Bydgoszcz, Poland
Uniwersyteckie Centrum Kliniczne, Klinika Onkologii I Radioterapii
Gdansk, Poland
Samodzielny Publiczny Zakład Opieki Zdrowotnej
Olsztyn, Poland
Samodzielny Publiczny ZOZ Opolskiego Centrum Onkologii w Opolu im. T. Koszarowskiego
Opole, Poland
Wielkopolskie Centrum Onkologii, im Marii Sklodowskiej-Curie
Poznan, Poland
...and 30 more locations